BDO advises capiton and KD Pharma Group on the acquisition of dsm-firmenich’s Marine Lipids Business
BDO advises capiton and KD Pharma Group on the acquisition of dsm-firmenich’s Marine Lipids Business
BDO has advised private equity specialist capiton AG and its portfolio company KD Pharma Group, a leading CDMO (Contract Manufacturing Organisation) in pharmaceutical and nutritional lipids, on the acquisition of the Marine Lipids business from dsm-firmenich, an innovator in the fields of nutrition, health and beauty.
A team from the Deal Advisory division of BDO AG Wirtschaftsprüfungsgesellschaft in Germany, led by Volkmar Berner (Partner Deal Advisory), conducted a comprehensive financial buy-side due diligence during the sale process.
As part of the transaction, dsm-firmenich will obtain a minority stake in KD Pharma and become a co-shareholder. The transaction will be closed in the course of 2024, subject to customary regulatory approvals, and includes dsm-firmenich's marine lipids omega-3 fish oil business for the food and beverage market, the dietary supplements market and the pharmaceutical market, as well as the production facilities in Piura, Peru, and Mulgrave, Canada.
The KD Pharma Group is a CDMO that develops products in the pharmaceutical and nutraceutical space. It is also the worldwide leading producer of API for Omega-3 pharmaceuticals and has built a similar market-leading position in Omega-3 nutraceuticals, formulation and encapsulation services, with over 500 employees and a presence in the UK, Norway, Germany, Switzerland and the US. The KD Pharma Group employs state-of-the-art technology which is protected by numerous patents.
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With a comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, they work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than EUR 12 billion. With a diverse, worldwide team of nearly 30,000 employees, dsm-firmenich brings progress to life every day, everywhere, for billions of people.
The BDO team consisted of
A team from the Deal Advisory division of BDO AG Wirtschaftsprüfungsgesellschaft in Germany, led by Volkmar Berner (Partner Deal Advisory), conducted a comprehensive financial buy-side due diligence during the sale process.
As part of the transaction, dsm-firmenich will obtain a minority stake in KD Pharma and become a co-shareholder. The transaction will be closed in the course of 2024, subject to customary regulatory approvals, and includes dsm-firmenich's marine lipids omega-3 fish oil business for the food and beverage market, the dietary supplements market and the pharmaceutical market, as well as the production facilities in Piura, Peru, and Mulgrave, Canada.
The KD Pharma Group is a CDMO that develops products in the pharmaceutical and nutraceutical space. It is also the worldwide leading producer of API for Omega-3 pharmaceuticals and has built a similar market-leading position in Omega-3 nutraceuticals, formulation and encapsulation services, with over 500 employees and a presence in the UK, Norway, Germany, Switzerland and the US. The KD Pharma Group employs state-of-the-art technology which is protected by numerous patents.
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With a comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, they work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than EUR 12 billion. With a diverse, worldwide team of nearly 30,000 employees, dsm-firmenich brings progress to life every day, everywhere, for billions of people.
The BDO team consisted of
- Volkmar Berner (Partner Financial Due Diligence, Munich)
- Felix Fries (Senior Manager Financial Due Diligence, Frankfurt)
- Vladimir Batalschtikov (Senior Manager Financial Due Diligence, Munich)